Massachusetts Eye And Ear Infirmary
Clinical trials sponsored by Massachusetts Eye And Ear Infirmary, explained in plain language.
-
Experimental drug AR-42 tested on brain tumors – early results uncertain
Disease control TerminatedThis early-phase trial tested the drug AR-42 in 7 adults with vestibular schwannoma or meningioma brain tumors who were already scheduled for surgery. Participants took AR-42 pills for about 3 weeks before their operation. The main goal was to see if the drug could lower a protei…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Glaucoma Drug-Eluting contact lens trial halted after single patient
Disease control TerminatedThis study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check safety and whether the lens could lower eye pressure, but no conclusi…
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New prism device may help one-eyed pedestrians avoid collisions
Symptom relief TerminatedThis study tested a prism device designed to expand the field of view for people who have lost vision in one eye. The goal was to see if the prism helps them detect pedestrians approaching from their blind side during a simulated walking task. Only one person participated before …
Phase: NA • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC